Cargando…
MNX1 reduces sensitivity to anoikis by activating TrkB in human glioma cells
Glioma is the most common type of malignant intracranial tumor in adults and is associated with the highest mortality rate. Although surgery, radiotherapy, chemotherapy and other treatment methods have progressed, the median survival of patients with glioma is only 14–15 months. Glioma cells are abl...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102707/ https://www.ncbi.nlm.nih.gov/pubmed/30066929 http://dx.doi.org/10.3892/mmr.2018.9329 |